Annex 22 marks a paradigm shift in pharmaceutical manufacturing, not only because it closes the longstanding “AI grey zone” ...

Large-language models are excellent for general-use AI systems, but they don’t understand pharmaceutical companies’ ...

The pharmaceutical industry’s approach to data integrity has been historically manual, leveraging physical documentation and potentially unreliable paper-based ...

Amit Singh is a global leader specializing in transformative AI and Master Data Management solutions. Please reach out to him on LinkedIn. In the highly regulated pharmaceutical industry, companies ...

CRM systems must evolve into intelligent networks integrating data, AI, and governance for effective orchestration in pharma. Unified data, embedded AI, and strategic governance form the foundation ...

Disruptions, whether positive, like the addition of new data sources, or challenging, such as supplier exits, are part of the natural evolution of open claims. Specific changes, such as expanded ...

DUBLIN--(BUSINESS WIRE)--The "Efficient Batch Record Design and Review" training has been added to ResearchAndMarkets.com's offering. This online training is designed for professionals in the ...

Linlin Sun and Xia Zheng of AFD China Intellectual Property Law Office cite two key Chinese Supreme People’s Court cases to clarify the conditions under which supplementary experimental data is ...

Pharma’s finally catching up: real-time data is helping teams move faster, stay compliant and deliver better care where it counts. In the rapidly evolving pharmaceutical and healthcare landscape, ...

Despite the Supreme Court’s proposal to lower the bar for post-filing patent data, innovators are sceptical that the provisions will have real impact Multinational pharmaceutical companies in China ...

Pharma marketing is shifting from a product-centered approach to one driven by data and engagement, according to Kamya Elawadhi, chief client officer at Doceree. In an interview with Fierce Pharma ...